Oxford COVID-19 vaccine is safe and protects against disease, first published results from phase 3 trials
Interim results of the Oxford COVID-19 vaccine trials find that the vaccine protects against symptomatic disease in 70% of cases—with …
Home »
AstraZeneca, J&J Resume U.S. COVID-19 Vaccine Trials
MONDAY, Oct. 26, 2020 — Drugmakers AstraZeneca and Johnson & Johnson are ready to resume paused COVID-19 vaccine trials after …
Keck School of Medicine promotes patient diversity in cardiac surgery clinical trials
A highly competitive $4.5 million grant from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) …
Drug that reverses memory loss from aging set for human trials
New drug that turns back the clock on memory loss from depression and aging makes the brain ‘youthful’ again – …